跳到正文
Longevity.Technology (@LongevityTech)· LongevityTech·· 6 天前评分8

ENHANCE-3 试验研究 ensifentrine 对 COPD 急性加重的影响

ENHANCE-3 will follow about 2,136 people for a year to investigate whether ensifentrine can reduce COPD exacerbations.

导读

ENHANCE-3 将随访约 2,136 人一年,研究 ensifentrine 能否减少 COPD 急性加重。 链接见首条评论。 #longevity #clinicaltrials #COPD #respiratoryhealth #biotech @Merck

来源:Longevity.Technology (@LongevityTech) · x.com